₄Ralph Schlapbach

Summary for 2006 [at-glance overview of Ralph Schlapbach work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Ralph Schlapbach. According to available data, in 2006 Ralph Schlapbach published at least 4 articles. This work was completed in collaboration with several authors including Wagner, Ulrich and Gehrig, Peter. Many other authors have collaborated with Ralph Schlapbach as well. There is no information about the funding or the grants awarded to support this work.

Analysis of the article abstracts and the titles suggests that Ralph Schlapbach professional interests are focused around "outgrowth endothelial cells", "late outgrowth endothelial" and "apoptosis xenobiotic metabolism". These might also be referred to as "endothelial cells", "gene expression" or "cord blood". Statistical analysis shows that Ralph Schlapbach's writing is likely to contains terms "cells", "genes", "expression", "quercetin", "cancer" and "mistletoe".

Unfortunately, there is not enough information to establish Ralph Schlapbach affiliation. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Ralph Schlapbach]

Do you know Ralph Schlapbach who matches the profile above? Click the photo and let us know!

Alternative names (0) [other authors with names similar to Ralph Schlapbach]

none

Year 2006 Charts [Ralph Schlapbach frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Ralph Schlapbach publication and funding history for the range of years]

Emails (2) [email addresses extracted from Ralph Schlapbach affiliations]

hidden to prevent spam, click here to reveal

Ralph Schlapbach Coauthors (15) [all coauthors with the number of joint publications]

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

Affiliations (4) [condensed summary of the Ralph Schlapbach affiliations, the leading number and the color conveys importance]

₁Rudjer Boskovic Institute, Division of Molecular Medicine, Bijenicka Cesta 54, 10002 Zagreb, Croatia.
₁Department of Obstetrics, University Hospital Zurich, Switzerland.
₁Biochemistry and Molecular Biotechnology Laboratory, Division of PHT, SK University of Agricultural Sciences and Technology, Shalimar Campus, Srinagar, Kashmir, India.
₁HSW, Hochschule Wädenswil, Wädenswil, Switzerland.

Key Opinion Leader In [Ralph Schlapbach is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

no keywords assigned

Keywords (32) [keywords assigned to Ralph Schlapbach articles by PubMed, the leading number and the color conveys importance]

₄Humans | ₂Cell Line, Tumor | ₂Up-Regulation | ₂Proteomics | ₂Gene Expression Profiling | ₂Oligonucleotide Array Sequence Analysis | ₁Malus | ₁Apoptosis | ₁Plant Proteins | ₁Gene Expression Regulation, Neoplastic | ₁Breast Neoplasms | ₁Electrophoresis, Gel, Two-Dimensional | ₁Superoxide Dismutase | ₁Lectins | ₁Abies | ₁Protein Array Analysis | ₁Quercetin | ₁Quercus | ₁Oxidative Stress | ₁Capillaries | ₁Xenobiotics | ₁Cell Cycle | ₁Pinus | ₁Fetal Blood | ₁RNA, Messenger | ₁Cells, Cultured | ₁RNA, Neoplasm | ₁Flavonoids | ₁Reactive Oxygen Species | ₁Gene Expression Regulation | ₁Neoplasms | ₁Down-Regulation

Ralph Schlapbach Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Ralph Schlapbach might be a good expert witness on these terms]

₁₉cells | ₁₃genes | ₁₂expression | ₁₀quercetin | ₁₀cancer | ₉mistletoe | ₈gene | ₈endothelial | ₈cell | ₆stress | ₆proteomics | ₆drug | ₆iscador | ₆response | ₅blood | ₅treatment | ₅mnsod | ₄oecs | ₄human | ₄specific | ₄co115 | ₄cord | ₄effect | ₄colon | ₄using | ₃colon-adenocarcinoma | ₃related | ₃study | ₃present | ₃can | ₃dna | ₃resistance
₆endothelial cells | ₆gene expression | ₄cord blood | ₃effect quercetin | ₃co115 colon-adenocarcinoma | ₃blood late | ₃apoptosis xenobiotic | ₃late outgrowth | ₃outgrowth endothelial | ₃oxidative stress | ₃cell-cycle arrest | ₃molecular mechanisms | ₃stress response | ₃xenobiotic metabolism | ₃mistletoe extracts | ₃colon cancer | ₃cancer cells | ₂cells accompanies | ₂molecular events | ₂point view | ₂genes related | ₂investigation demonstrating | ₂resistance oxidative | ₂robust resistance | ₂cells using | ₂mnsod marks | ₂gel electrophoresis | ₂marks cord | ₂dna microarray | ₂cells treated | ₂casting light | ₂arrest apoptosis
₃outgrowth endothelial cells | ₃late outgrowth endothelial | ₃apoptosis xenobiotic metabolism | ₃blood late outgrowth | ₂underlying anti-cancer drug | ₂drug treatment can | ₂can proteomics point | ₂events underlying anti-cancer | ₂two-dimensional gel electrophoresis | ₂light molecular events | ₂anti-cancer drug treatment | ₂casting light molecular | ₂treatment can proteomics | ₂differentially expressed genes | ₂proteomics point view | ₂molecular events underlying | ₂endothelial cells accompanies | ₂mnsod marks cord | ₂human co115 colon-adenocarcinoma | ₂genes related cell-cycle | ₂xenobiotic metabolism human | ₂robust resistance oxidative | ₂quercetin expression genes | ₂marks cord blood | ₂arrest apoptosis xenobiotic | ₂cord blood late | ₂cells accompanies robust | ₂related cell-cycle arrest | ₂demonstrating effect quercetin | ₂investigation demonstrating effect | ₂colon-adenocarcinoma cells using | ₂accompanies robust resistance

Reader's Comments (0) [comments posted by readers of Ralph Schlapbach profile]